We've found
184,457
clinical trials
We've found
184,457
clinical trials
Lennox-Gastaut Syndrome (LGS) Clinical Trial
Updated: 12/31/1969
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Lennox-Gastaut Syndrome (LGS) Clinical Trial
Updated: 12/31/1969
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Rheumatology Clinical Trial
Updated: 12/31/1969
Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Hematology Clinical Trial
Updated: 12/31/1969
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/31/1969
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Alzheimer's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Subjects With NSCLC With an EGFR Activating Mutation Clinical Trial
Updated: 4/13/2017
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study
Status: Enrolling,
Phase
II
Updated: 4/13/2017
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Head and Neck Neoplasms Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cushing Syndrome Clinical Trial
Updated: 12/31/1969
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Severe Preeclampsia Clinical Trial
Updated: 12/31/1969
Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 3/21/2018
Study the Use of Magseed and Sentimag to Localize Axillary Lymph Nodes
Status: Enrolling,
Phase
IV
Updated: 3/21/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 5/1/2018
PEEP and V/Q Mismatch in Premature Infants
Status: Enrolling,
Phase
I, II
Updated: 5/1/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 5/1/2018
PEEP and V/Q Mismatch in Premature Infants
Status: Enrolling,
Phase
I, II
Updated: 5/1/2018
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Epilepsy Clinical Trial
Updated: 12/31/1969
Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Combination With Intratumoral SD-101 Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Heart Failure Clinical Trial
Updated: 12/31/1969
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cancer Clinical Trial
Updated: 12/31/1969
Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer.
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Developmental Dysplasia of the Hip Clinical Trial
Updated: 12/31/1969
Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow After Surgical Hip Reduction for DDH
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Cancer Clinical Trial
Updated: 12/31/1969
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Advanced Cancer Clinical Trial
Updated: 12/31/1969
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Viral Infections Clinical Trial
Updated: 12/31/1969
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Biliary Cirrhosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Biliary Cirrhosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Biliary Cirrhosis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Updated: 12/31/1969
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Updated: 12/31/1969
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology, Otolaryngology Clinical Trial
Updated: 12/31/1969
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Nephrology / Urology, Reproductive Clinical Trial
Updated: 12/31/1969
Timing of Repeat Voiding Trials After Outpatient Pelvic Floor Surgery
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Locally Advanced Esophageal and Gastric Cancers (EGC) Clinical Trial
Updated: 12/31/1969
Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HSV Infection Clinical Trial
Updated: 12/31/1969
Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Adults
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Clinical Trial
Updated: 12/31/1969
Interactive Digital Health Tools to Improve Patient Safety in Acute Care
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Clinical Trial
Updated: 12/31/1969
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

RHEUMATOID ARTHRITIS Clinical Trial
Updated: 12/31/1969
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
